Replacing universal anti-neuronal antibody screening with clinical assessment and testing of high probability cases in psychotic disorders.

Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: N.W. has received speaker fees from Otsuka, Lundbeck and Janssen. The employers (The University of Queensland and QIMR Berghofer Medical Research Institute) of J.G.S. have received fees for him speaking at Lundbeck, Otsuka and Janssen events. G.M. has no conflicts to declare.